Clinical Trial Update: Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma [NA]

View source ↗

Summary

A clinical study evaluating epigenetic and inflammatory markers of accelerated biological aging in patients with Hodgkin lymphoma in remission; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Hodgkin Lymphoma in Remission | NA | Status: RECRUITING